甲状腺眼症（TED）の世界市場レポート 2025年

甲状腺眼症（TED）市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.6％で29億7,000万米ドルに成長します。予測期間中の成長は、バセドウ病有病率の上昇、様々な産業における資金調達の増加、ヘルスケア支出の増加、甲状腺ホルモン補充療法の利用拡大、甲状腺疾患の罹患率の上昇によって牽引される可能性があります。この期間の主要動向には、技術の発展、研究開発活動の拡大、新薬の開発、治療選択肢の改善、新しい手術手技の導入などがあります。

甲状腺疾患の有病率の増加は、甲状腺眼症（TED）市場の拡大を促進すると予想されます。甲状腺疾患は、甲状腺の機能を乱し、ホルモンの不均衡や甲状腺機能低下症、甲状腺機能亢進症、甲状腺腫、甲状腺眼症などの状態を引き起こす病状です。甲状腺疾患の罹患率の増加は、ヨード摂取量の増加、自己免疫疾患、遺伝的素因、診断率の向上につながる認知度の向上などの要因によるものです。甲状腺眼症（TED）は、バセドウ病の重篤かつ一般的な合併症であるため、甲状腺疾患の症例数の増加において重要な役割を果たしており、甲状腺関連疾患の全体的な負担と認知度の向上に寄与しています。例えば、2024年5月、カナダを拠点とする非営利団体であるカナダがん協会は、2024年にカナダで基本推定6,600例の甲状腺がんが新たに診断され、約280例の死亡が予測されると報告しました。その結果、甲状腺疾患の有病率の増加が甲状腺眼症（TED）市場の成長に拍車をかけています。

甲状腺眼症（TED）市場の主要企業は、モノクローナル抗体療法などの革新的な治療法の開発を優先し、炎症を抑え、眼瞼下垂を改善し、患者の転帰全体を向上させる、より効果的で的を絞ったソリューションを提供しています。モノクローナル抗体療法は、特定の病原体や異常な細胞を認識し中和する免疫系の能力を模倣するように設計された、実験室で操作された抗体を含みます。例えば、2024年9月、米国のバイオテクノロジー企業であるアムジェン社は、日本の厚生労働省が、視力を脅かす可能性のある希少な自己免疫疾患である活動性甲状腺眼症（TED）の治療としてテペザ（テプロツムマブ）を承認したと発表しました。テペザは、TEDに特化した治療として初めてFDAに承認された唯一の治療であり、炎症、腫脹、その他TEDに関連する衰弱症状を軽減する標的治療です。今回の承認は、重度の眼球膨隆、視力障害、眼の疼痛を引き起こす進行性の疾患であるTEDの管理に有効な新たな選択肢をもたらすものであり、日本の患者さんにとって特に意義深いものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の甲状腺眼症（TED） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の甲状腺眼症（TED）市場：成長率分析
• 世界の甲状腺眼症（TED）市場の実績：規模と成長、2019～2024年
• 世界の甲状腺眼症（TED）市場の予測：規模と成長、2024～2029年、2034年
• 世界の甲状腺眼症（TED）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の甲状腺眼症（TED）市場治療タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 医療
• 外科
• 内科と外科の組み合わせ
• 世界の甲状腺眼症（TED）市場：病気の重症度別、実績と予測、2019～2024年、2024～2029年、2034年
• 軽度
• 中度
• 重度
• 世界の甲状腺眼症（TED）市場：薬剤タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 生物製剤
• 小分子
• その他の薬剤タイプ
• 世界の甲状腺眼症（TED）市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 静脈内
• 皮下
• 世界の甲状腺眼症（TED）市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• その他
• 世界の甲状腺眼症（TED）市場、医療のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• コルチコステロイド
• テプロツムマブ
• 抗甲状腺薬
• その他の医療処置
• 世界の甲状腺眼症（TED）市場、外科のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 眼窩減圧手術
• まぶたの手術
• 斜視手術
• 世界の甲状腺眼症（TED）市場、内科と外科の組み合わせのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• コルチコステロイドと眼窩減圧術の併用
• テプロツムマブと眼瞼手術の併用
• その他の複合アプローチ

第7章 地域別・国別分析

• 世界の甲状腺眼症（TED）市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の甲状腺眼症（TED）市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 甲状腺眼症（TED）市場：競合情勢
• 甲状腺眼症（TED）市場：企業プロファイル
  • Hoffmann-La Roche AG
  • Amgen Inc.
  • Genentech Inc.
  • Horizon Therapeutics plc
  • Pierre Fabre S.A.

第31章 その他の大手企業と革新的企業

• Innovent Biologics Inc.
• ACELYRIN Inc.
• Soleo Health
• Zai Lab Limited
• HanAll Biopharma Co. Ltd.
• Tourmaline Bio Inc.
• Zenas BioPharma Inc.
• Immunovant Inc.
• Verana Health
• Harbour BioMed（Guangzhou）Co. Ltd.
• Sling Therapeutics Inc.
• Crinetics Pharmaceuticals Inc.
• Lassen Therapeutics Inc.
• Viridian Therapeutics Inc.
• Minghui Pharmaceutical Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 甲状腺眼症（TED）市場、2029年：新たな機会を提供する国
• 甲状腺眼症（TED）市場、2029年：新たな機会を提供するセグメント
• 甲状腺眼症（TED）市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Thyroid eye disease (TED), also known as Graves' Orbitopathy, is an autoimmune disorder marked by inflammation and swelling of the tissues surrounding the eyes, often linked to thyroid conditions. TED can lead to symptoms such as bulging eyes, double vision, and eye discomfort.

The primary treatment approaches for TED include medical, surgical, and a combination of both. Medical management typically involves corticosteroids, immunosuppressive drugs, and biologic therapies to reduce inflammation, alleviate symptoms, and prevent disease progression. Treatment is customized based on disease severity, classified into mild, moderate, and severe stages. The drugs used belong to various categories, including biologics, small molecules, and others. They are administered through different routes, such as oral, intravenous, and subcutaneous methods, and are utilized by various end users, including hospitals, clinics, and other healthcare facilities.

The thyroid eye disease (TED) market research report is one of a series of new reports from The Business Research Company that provides thyroid eye disease (TED) market statistics, including the thyroid eye disease (TED) industry global market size, regional shares, competitors with the thyroid eye disease (TED) market share, detailed thyroid eye disease (TED) market segments, market trends, and opportunities, and any further data you may need to thrive in the thyroid eye disease (TED) industry. This thyroid eye disease (TED) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The thyroid eye disease (TED) market size has grown strongly in recent years. It will grow from $2.15 billion in 2024 to $2.30 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth during the historic period can be attributed to the rising incidence of thyroid disorders, a growing emphasis on patient-centered care, increasing demand for cosmetic procedures, a higher prevalence of the disease, and the expansion of treatment options for TED.

The thyroid eye disease (TED) market size is expected to see strong growth in the next few years. It will grow to $2.97 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth during the forecast period can be driven by the rising prevalence of Graves' disease, increased funding across various industries, growing healthcare expenditure, greater use of thyroid hormone replacement therapy, and a higher incidence of thyroid disease. Key trends in this period include technological advancements, expanding R&D activities, the development of novel drugs, improvements in treatment options, and the introduction of new surgical techniques.

The increasing prevalence of thyroid disorders is expected to drive the expansion of the thyroid eye disease (TED) market. Thyroid disorders are medical conditions that disrupt the function of the thyroid gland, leading to hormonal imbalances and conditions such as hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease. The rising incidence of thyroid disorders is attributed to factors such as increased iodine intake, autoimmune diseases, genetic predisposition, and improved awareness leading to higher diagnostic rates. Thyroid Eye Disease (TED) plays a significant role in the growing number of thyroid disorder cases, as it is a serious and common complication of Graves' disease, contributing to the overall burden and awareness of thyroid-related conditions. For example, in May 2024, the Canadian Cancer Society, a Canada-based non-profit organization, reported that an estimated 6,600 new cases of thyroid cancer are expected to be diagnosed in Canada in 2024, with approximately 280 projected fatalities. As a result, the increasing prevalence of thyroid disorders is fueling the growth of the thyroid eye disease (TED) market.

Leading companies in the thyroid eye disease (TED) market are prioritizing the development of innovative treatments, such as monoclonal antibody therapies, to provide more effective, targeted solutions that reduce inflammation, improve proptosis, and enhance overall patient outcomes. Monoclonal antibody therapies involve laboratory-engineered antibodies designed to mimic the immune system's ability to recognize and neutralize specific pathogens or abnormal cells. For instance, in September 2024, Amgen Inc., a US-based biotechnology company, announced that Japan's Ministry of Health, Labour and Welfare (MHLW) had approved TEPEZZA (teprotumumab) for the treatment of active thyroid eye disease (TED), a rare and potentially vision-threatening autoimmune disorder. TEPEZZA is the first and only FDA-approved therapy specifically for TED, offering a targeted treatment that helps reduce inflammation, swelling, and other debilitating symptoms associated with the disease. This approval is particularly significant for patients in Japan, as it introduces an effective new option for managing TED, a progressive condition that can cause severe eye bulging, vision impairment, and eye pain.

In October 2023, Amgen Inc., a US-based biopharmaceutical company, acquired Horizon Therapeutics plc for an undisclosed amount. This acquisition strengthens Amgen's rare and inflammatory disease portfolio by integrating Horizon's key therapies, expanding its global reach, and driving innovation for long-term growth. Horizon Therapeutics plc, an Ireland-based company, specializes in treatments for rare autoimmune and inflammatory diseases.

Major players in the thyroid eye disease (ted) market are Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.

North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in thyroid eye disease (TED) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the thyroid eye disease (TED) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The thyroid eye disease (TED) market includes revenues earned by entities by providing services such as diagnosis services, pharmaceutical services, surgical services, support, and counseling services and related products including thyroid hormone replacement therapy, immunosuppressive drugs, surgical products, and devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Thyroid Eye Disease (TED) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on thyroid eye disease (ted) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for thyroid eye disease (ted) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The thyroid eye disease (ted) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Medical; Surgical; Combination Of Medical And Surgical
• 2) By Disease Severity: Mild; Moderate; Severe
• 3) By Drug Type: Biologics; Small Molecules; Others Drug Type
• 4) By Route Of Administration: Oral; Intravenous; Subcutaneous
• 5) By End User: Hospitals; Clinics; Other End Users
• Subsegments:
• 1) By Medical: Corticosteroids; Teprotumumab; Antithyroid Medications; Other Medical Treatments
• 2) By Surgical: Orbital Decompression Surgery; Eyelid Surgery; Strabismus Surgery
• 3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression; Combination of Teprotumumab and Eyelid Surgery; Other Combined Approaches
• Companies Mentioned: Hoffmann-La Roche AG; Amgen Inc.; Genentech Inc.; Horizon Therapeutics plc; Pierre Fabre S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Thyroid Eye Disease (TED) Market Characteristics

3. Thyroid Eye Disease (TED) Market Trends And Strategies

4. Thyroid Eye Disease (TED) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Thyroid Eye Disease (TED) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Thyroid Eye Disease (TED) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Thyroid Eye Disease (TED) Market Growth Rate Analysis
• 5.4. Global Thyroid Eye Disease (TED) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Thyroid Eye Disease (TED) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Thyroid Eye Disease (TED) Total Addressable Market (TAM)

6. Thyroid Eye Disease (TED) Market Segmentation

• 6.1. Global Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical
• Surgical
• Combination Of Medical And Surgical
• 6.2. Global Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild
• Moderate
• Severe
• 6.3. Global Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologics
• Small Molecules
• Others Drug Type
• 6.4. Global Thyroid Eye Disease (TED) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Subcutaneous
• 6.5. Global Thyroid Eye Disease (TED) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End Users
• 6.6. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Medical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Teprotumumab
• Antithyroid Medications
• Other Medical Treatments
• 6.7. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Orbital Decompression Surgery
• Eyelid Surgery
• Strabismus Surgery
• 6.8. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Combination Of Medical And Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Combination Of Corticosteroids And Orbital Decompression
• Combination Of Teprotumumab And Eyelid Surgery
• Other Combined Approaches

7. Thyroid Eye Disease (TED) Market Regional And Country Analysis

• 7.1. Global Thyroid Eye Disease (TED) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Thyroid Eye Disease (TED) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Thyroid Eye Disease (TED) Market

• 8.1. Asia-Pacific Thyroid Eye Disease (TED) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Thyroid Eye Disease (TED) Market

• 9.1. China Thyroid Eye Disease (TED) Market Overview
• 9.2. China Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Thyroid Eye Disease (TED) Market

• 10.1. India Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Thyroid Eye Disease (TED) Market

• 11.1. Japan Thyroid Eye Disease (TED) Market Overview
• 11.2. Japan Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Thyroid Eye Disease (TED) Market

• 12.1. Australia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Thyroid Eye Disease (TED) Market

• 13.1. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Thyroid Eye Disease (TED) Market

• 14.1. South Korea Thyroid Eye Disease (TED) Market Overview
• 14.2. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Thyroid Eye Disease (TED) Market

• 15.1. Western Europe Thyroid Eye Disease (TED) Market Overview
• 15.2. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Thyroid Eye Disease (TED) Market

• 16.1. UK Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Thyroid Eye Disease (TED) Market

• 17.1. Germany Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Thyroid Eye Disease (TED) Market

• 18.1. France Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Thyroid Eye Disease (TED) Market

• 19.1. Italy Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Thyroid Eye Disease (TED) Market

• 20.1. Spain Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Thyroid Eye Disease (TED) Market

• 21.1. Eastern Europe Thyroid Eye Disease (TED) Market Overview
• 21.2. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Thyroid Eye Disease (TED) Market

• 22.1. Russia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Thyroid Eye Disease (TED) Market

• 23.1. North America Thyroid Eye Disease (TED) Market Overview
• 23.2. North America Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Thyroid Eye Disease (TED) Market

• 24.1. USA Thyroid Eye Disease (TED) Market Overview
• 24.2. USA Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Thyroid Eye Disease (TED) Market

• 25.1. Canada Thyroid Eye Disease (TED) Market Overview
• 25.2. Canada Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Thyroid Eye Disease (TED) Market

• 26.1. South America Thyroid Eye Disease (TED) Market Overview
• 26.2. South America Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Thyroid Eye Disease (TED) Market

• 27.1. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Thyroid Eye Disease (TED) Market

• 28.1. Middle East Thyroid Eye Disease (TED) Market Overview
• 28.2. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Thyroid Eye Disease (TED) Market

• 29.1. Africa Thyroid Eye Disease (TED) Market Overview
• 29.2. Africa Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Thyroid Eye Disease (TED) Market Competitive Landscape And Company Profiles

• 30.1. Thyroid Eye Disease (TED) Market Competitive Landscape
• 30.2. Thyroid Eye Disease (TED) Market Company Profiles
  • 30.2.1. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Horizon Therapeutics plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Pierre Fabre S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Thyroid Eye Disease (TED) Market Other Major And Innovative Companies

• 31.1. Innovent Biologics Inc.
• 31.2. ACELYRIN Inc.
• 31.3. Soleo Health
• 31.4. Zai Lab Limited
• 31.5. HanAll Biopharma Co. Ltd.
• 31.6. Tourmaline Bio Inc.
• 31.7. Zenas BioPharma Inc.
• 31.8. Immunovant Inc.
• 31.9. Verana Health
• 31.10. Harbour BioMed (Guangzhou) Co. Ltd.
• 31.11. Sling Therapeutics Inc.
• 31.12. Crinetics Pharmaceuticals Inc.
• 31.13. Lassen Therapeutics Inc.
• 31.14. Viridian Therapeutics Inc.
• 31.15. Minghui Pharmaceutical Inc.

32. Global Thyroid Eye Disease (TED) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Thyroid Eye Disease (TED) Market

34. Recent Developments In The Thyroid Eye Disease (TED) Market

35. Thyroid Eye Disease (TED) Market High Potential Countries, Segments and Strategies

• 35.1 Thyroid Eye Disease (TED) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Thyroid Eye Disease (TED) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Thyroid Eye Disease (TED) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer